Search research articles
Contact Us
Filters
Showing results (1-10 of 81) with videos related to
Page
of 9
Sort By:
Schweizerische Medizinische Wochenschrift
|
June 17, 1995
[CA 125--a tumor marker?]
T Pabst, C Ludwig
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1995
CA-125: a tumor marker in non-Hodgkin's lymphomas?
T Pabst, C Ludwig
Praxis
|
May 23, 1998
[Sarcoidosis and subclinical hyperthyroidism]
T Pabst, G Huber
Oncogene
|
October 16, 2007
Transcriptional dysregulation during myeloid transformation in AML
T Pabst, B U Mueller
The Journal of Comparative Neurology
|
January 23, 1995
Development of the hippocamposeptal projection in the rat
R Linke, T Pabst, M Frotscher
VASA. Zeitschrift Fur Gefasskrankheiten
|
September 19, 2002
High resolution contrast enhanced MR-angiography of the hand arteries: preliminary experiences
U Krause, T Pabst, W Kenn, et al.
British Journal of Haematology
|
October 1, 1996
Detection of microsatellite markers in leukaemia using DNA from archival bone marrow smears
T Pabst, J Schwaller, A Tobler, et al.
British Journal of Cancer
|
March 12, 2009
Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favourable prognosis
T Pabst, M Eyholzer, J Fos, et al.
The Breast Journal
|
July 27, 2001
Understanding why contrast enhancement in dynamic MRI is not reproducible: illustration with a simple phantom
T Pabst, W Kenn, W A Kaiser, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|
April 5, 2003
[Primary diagnosis of coronary artery disease by MRI and CT]
J Sandstede, M Beer, T Pabst, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 81) with videos related to
Sort By:
Page
of 9
Schweizerische Medizinische Wochenschrift
|
June 17, 1995
[CA 125--a tumor marker?]
T Pabst, C Ludwig
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1995
CA-125: a tumor marker in non-Hodgkin's lymphomas?
T Pabst, C Ludwig
Praxis
|
May 23, 1998
[Sarcoidosis and subclinical hyperthyroidism]
T Pabst, G Huber
Oncogene
|
October 16, 2007
Transcriptional dysregulation during myeloid transformation in AML
T Pabst, B U Mueller
The Journal of Comparative Neurology
|
January 23, 1995
Development of the hippocamposeptal projection in the rat
R Linke, T Pabst, M Frotscher
VASA. Zeitschrift Fur Gefasskrankheiten
|
September 19, 2002
High resolution contrast enhanced MR-angiography of the hand arteries: preliminary experiences
U Krause, T Pabst, W Kenn, et al.
British Journal of Haematology
|
October 1, 1996
Detection of microsatellite markers in leukaemia using DNA from archival bone marrow smears
T Pabst, J Schwaller, A Tobler, et al.
British Journal of Cancer
|
March 12, 2009
Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favourable prognosis
T Pabst, M Eyholzer, J Fos, et al.
The Breast Journal
|
July 27, 2001
Understanding why contrast enhancement in dynamic MRI is not reproducible: illustration with a simple phantom
T Pabst, W Kenn, W A Kaiser, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|
April 5, 2003
[Primary diagnosis of coronary artery disease by MRI and CT]
J Sandstede, M Beer, T Pabst, et al.
Page
of 9